These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ultrastructural studies of vitiligo, Vogt-Koyanagi syndrome, and incontinentia pigmenti achromians. Morohashi M; Hashimoto K; Goodman TF; Newton DE; Rist T Arch Dermatol; 1977 Jun; 113(6):755-66. PubMed ID: 869545 [TBL] [Abstract][Full Text] [Related]
8. Cytokines: the yin and yang of vitiligo pathogenesis. Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555 [TBL] [Abstract][Full Text] [Related]
9. [Vitiligo]. Njoo MD; Westerhof W Ned Tijdschr Geneeskd; 1997 Apr; 141(16):759-64. PubMed ID: 9213796 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513 [TBL] [Abstract][Full Text] [Related]
11. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Dell'anna ML; Picardo M Pigment Cell Res; 2006 Oct; 19(5):406-11. PubMed ID: 16965269 [TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to melanocytes in vitiligo by western immunoblotting. Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487 [TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo. Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological study of vitiligo in Surat area, South Gujarat. Mehta NR; Shah KC; Theodore C; Vyas VP; Patel AB Indian J Med Res; 1973 Jan; 61(1):145-54. PubMed ID: 4756867 [No Abstract] [Full Text] [Related]
16. Electron microscopy of peripheral nerve terminals and marginal melanocytes in vitiligo. Breathnach AS; Bor S; Wyllie LM J Invest Dermatol; 1966 Aug; 47(2):125-40. PubMed ID: 4288122 [No Abstract] [Full Text] [Related]
17. Modern aspects of vitiligo pathogenesis. Korsunskaya IM; Suvorova KN; Dvoryankova EV Dokl Biol Sci; 2003; 388():38-40. PubMed ID: 12705126 [No Abstract] [Full Text] [Related]
18. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041 [TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of vitiligo. Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of vitiligo lesions reveals sporadic melanocyte survival. Gottschalk GM; Kidson SH Int J Dermatol; 2007 Mar; 46(3):268-72. PubMed ID: 17343582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]